Related references
Note: Only part of the references are listed.Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis-Interstitial Lung Disease Open-Label Extension of a Phase 3 Randomized Controlled Trial
Dinesh Khanna et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Chest wall muscle atrophy as a contributory factor for forced vital capacity decline in systemic sclerosis-associated interstitial lung disease
Takashi Nawata et al.
RHEUMATOLOGY (2021)
Elastic Registration-driven Deep Learning for Longitudinal Assessment of Systemic Sclerosis Interstitial Lung Disease at CT
Guillaume Chassagnon et al.
RADIOLOGY (2021)
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease
Louis Chauvelot et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung Disease
David Roofeh et al.
ARTHRITIS & RHEUMATOLOGY (2021)
A Comparative Evaluation of Computed Tomography Images for the Classification of Spirometric Severity of the Chronic Obstructive Pulmonary Disease with Deep Learning
Hiroyuki Sugimori et al.
DIAGNOSTICS (2021)
Deep learning for screening of interstitial lung disease patterns in high-resolution CT images
S. Agarwala et al.
CLINICAL RADIOLOGY (2020)
Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances
Masaru Kato et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Deep Learning-based Approach for Automated Assessment of Interstitial Lung Disease in Systemic Sclerosis on CT Images
Guillaume Chassagnon et al.
RADIOLOGY-ARTIFICIAL INTELLIGENCE (2020)
Prevalence, Treatment, and Outcomes of Coexistent Pulmonary Hypertension and Interstitial Lung Disease in Systemic Sclerosis
Amber Young et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Novel Imaging Approaches in Systemic Sclerosis-Associated Interstitial Lung Disease
Sydney B. Montesi et al.
CURRENT RHEUMATOLOGY REPORTS (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Pulmonary hypertension in chronic lung disease and hypoxia
Steven D. Nathan et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic Analysis
Joseph Jacob et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II
Jonathan G. Goldin et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Kathleen Morrisroe et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes
Margaret L. Salisbury et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Quantitative chest CT analysis in patients with systemic sclerosis before and after autologous stem cell transplantation: comparison of results with those of pulmonary function tests and clinical tests
Christopher Kloth et al.
RHEUMATOLOGY (2016)
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Olivier Sitbon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
N. Galie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Bosentan in Pulmonary Hypertension Associated with Fibrotic Idiopathic Interstitial Pneumonia
Tamera J. Corte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
Marius M. Hoeper et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Pulmonary Hypertension in Chronic Lung Diseases
Werner Seeger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
Tomas Pulido et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Screening for Pulmonary Arterial Hypertension in Patients With Systemic Sclerosis Clinical Characteristics at Diagnosis and Long-Term Survival
Marc Humbert et al.
ARTHRITIS AND RHEUMATISM (2011)
Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide
Hyun J. Kim et al.
EUROPEAN RADIOLOGY (2011)
Interleukin-6 as a Potential Therapeutic Target for Pulmonary Arterial Hypertension
Yoshiaki Furuya et al.
INTERNATIONAL JOURNAL OF RHEUMATOLOGY (2010)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Share Paper
